I'll research J (Jacobs Solutions) before writing the preview. Let me start gathering data.Let me read the most recent earnings materials and get recent price/news context.Let me get recent stock price performance and check the year-ago Q3 for comparables.Let me pull the year-ago Q3 figures for YoY framing and check recent analyst/news activity.# Jacobs Solutions (NYSE: J) — Fiscal Q3 2026 Earnings Preview
Jacobs heads into its fiscal Q3 print with genuine business momentum — a record backlog, an accelerating AI/data-center growth engine, and management having raised full-year guidance in each of the last two quarters — but with a stock that has repeatedly sold off on good news. The key question is whether an in-line-to-strong quarter is enough given elevated expectations and a couple of modeling wrinkles (taxes, GAAP optics) that could muddy the headline.
On the May call, CFO Venk Nathamuni gave unusually specific Q3 framing: - Adjusted net revenue growth of ~7.5% y/y (a step down from Q2's +9%, and implying roughly ~$2.4B vs. $2.23B a year ago). - Adjusted EBITDA margin of ~15%, which would be ~90 bps of sequential improvement from Q2's 14.1% and ~90 bps above the year-ago 14.1%. - This sets up an implied Q4 margin above 16% on double-digit top-line growth, aided by an extra (14th) week in the fiscal fourth quarter.
Watch the tax rate. Management guided the adjusted effective tax rate to 27–28% in both Q3 and Q4, versus just 24.3% in Q2. That is a real EPS headwind — margin expansion and buybacks will be partly offset by a higher tax drag, so don't expect the same 20%+ adjusted EPS growth cadence to flow straight through.
Full-year (FY26) guidance to check against: - Adjusted net revenue growth 8.0%–10.5% - Adjusted EBITDA margin 14.6%–14.9% - Adjusted EPS $7.10–$7.35 (≈18% y/y growth at the midpoint) - Adjusted FCF margin 7.0%–8.5%
With first-half adjusted EPS of $3.28 ($1.53 in Q1 + $1.75 in Q2) already booked, the back half needs to deliver roughly $3.82–$4.07. A third straight guidance raise is plausible given the two-quarter track record — but after two raises, the bar for a positive reaction is higher. Watch whether they narrow to the upper half vs. raise outright.
This is where the incremental buy-side debate sits. On the last call, management quantified it clearly: - The data-center business is ~3–4% of revenue and grew >100% y/y in Q2. - The broader AI ecosystem (chips → power/energy → data centers) is ~10–11% of the business and growing 40%+. - The data-center pipeline is up ~400% y/y, with visibility "well through '27 into '28," anchored by the NVIDIA partnership (digital twins via the Omniverse DSX Blueprint, plan-of-record work extending to next-gen Vera Rubin).
For Q3, investors will want confirmation that this triple-digit data-center growth and the semiconductor/power/water pull-through are sustaining, not decelerating. Any hard numbers on data-center bookings, hyperscaler + "neocloud" wins, and semiconductor reshoring (management sees a return toward prior-peak CapEx into FY27) will move the stock more than the headline EPS.
Backlog is the cleanest read on durability. Q2 set a record $27.0B (+22% y/y) with a 1.2x quarterly book-to-bill (1.4x TTM gross, 1.2x net). Year-ago Q3 backlog was $22.69B at a 1.2x book-to-bill. Keep an eye on: - Whether book-to-bill holds above 1.0x and backlog sets another record. - Gross profit / net revenue in backlog (up 15%/12% y/y in Q2) — a proxy for future margin and organic growth quality. - Life sciences (pipeline was up 81%) and environmental, the one soft spot management said should show "meaningful improvement" by Q4.
Two reporting segments: Infrastructure & Advanced Facilities (I&AF) and PA Consulting. - PA Consulting is now 100%-owned (transaction closed March 20, 2026) and has posted four straight quarters of double-digit revenue growth (+17% in Q2), at a ~22% operating margin — accretive to mix. Watch for early revenue synergies (conflict-of-interest restrictions on joint pipeline are now removed) and cost synergies, guided to $20M+ within 24 months (real estate, procurement, IT). - Margin trajectory is the long-term equity story: management raised the FY29 adjusted EBITDA margin target to 17%+ (from 16%+) and the FCF margin target to 11%+, implying $1.2–1.3B of annual FCF by FY29. Any commentary reinforcing the ~75 bps/year of identified improvement supports the multiple.
Despite the fundamental momentum, the stock has struggled to hold gains on earnings: - After the Q4 FY25 report (Nov 20, 2025), shares fell ~11% (≈$145 → $129). - After the Q2 FY26 report (May 5, 2026) — which included a guidance raise — the stock dropped from ~$137 to ~$107 within a week. - Shares have since recovered to ~$139 (Aug 3), roughly flat-to-down vs. ~$145 a year ago, meaning the multiple has de-rated even as estimates rose.
The takeaway: the market appears to be holding J to a high bar, and "beat-and-raise" may already be the base case. Positioning and the recent run-up into the print (up from ~$118 in late May) raise the risk that anything short of a clean beat + raise + reassuring AI commentary gets sold.
Note on data: figures above are drawn from Jacobs' fiscal Q2 2026 and Q3 2025 earnings releases and the Q2 2026 conference call. No fresh company-specific news or pre-announcements were available in the days immediately ahead of this report. Consensus estimates were not available in the sources reviewed, so peg results against management's own guidance framework above.